HHS secretary Alex Azar at the CDC, Oct. 21, 2020 (Alyssa Pointer/Atlanta Journal-Constitution via AP)

Alex Azar, re­fus­ing to ac­knowl­edge elec­tion re­sults, says they're not work­ing with Biden team on vac­cine roll­out

With da­ta now out on two ex­per­i­men­tal vac­cines, the course of the rag­ing US out­break and the suc­cess of the fed­er­al gov­ern­ment’s $18 bil­lion vac­cine ac­cel­er­a­tion pro­gram hinges in part on whether of­fi­cials can suc­cess­ful­ly roll dos­es out to the gen­er­al pub­lic, should they re­ceive FDA au­tho­riza­tion.

It’s a del­i­cate and high­ly tech­ni­cal process, one that of­fi­cials have been game-plan­ning in mil­i­tary table­top style for months. But so far nei­ther those of­fi­cials nor oth­er rep­re­sen­ta­tives from the fed­er­al gov­ern­ment have spo­ken to the ad­min­is­tra­tion that will take over just a month in­to the like­ly roll­out, HHS sec­re­tary Alex Azar said Wednes­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.